Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.240
-0.020 (-1.59%)
May 26, 2026, 2:15 PM EDT - Market open
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$789,186
Market Cap
4.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | 1 | 12.50% |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 33 |
| Virax Biolabs Group | 19 |
| Cardio Diagnostics Holdings | 17 |
| FibroBiologics | 15 |
| BioRestorative Therapies | 14 |
| CDT Equity | 4 |
| Mustang Bio | 4 |
| Pulmatrix | 2 |
DRMA News
- 12 days ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - Accesswire
- 7 weeks ago - Dermata receives notice of acceptance of Australian patent application - TheFly
- 7 weeks ago - Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - Accesswire
- 7 weeks ago - Dermata Therapeutics price target lowered to $4 from $10 at Maxim - TheFly
- 2 months ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Accesswire
- 2 months ago - Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing - TheFly
- 2 months ago - Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Accesswire
- 2 months ago - Dermata Therapeutics announces release of Tome Skincare - TheFly